Monographie - Epirubicin hydrochloride

Viimeisin päivitys :
19/11/2024

Epirubicin hydrochloride

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anthracine	Malesia
Axirubicine	Saksa
Bendaepi	Saksa
Binarin	Meksiko
Bioepycina	Puola
Crisabon	Argentiina
Cuatroepi	Argentiina
Ecclepia	Romania
Elebicin	Meksiko
Ellence	Yhdysvallat
Epi Cell	Saksa
Epidoxo	Argentiina, Chile, Venezuela
Epifil	Ecuador
Epilem	Kolumbia, Meksiko
Epimedac	Saksa
Epirubicin	Australia, Belgia, Islanti, Iso-Britannia, Itävalta, New Zealand, Ruotsi, Saudi-Arabia, Sveitsi, Tanska, Turkki, Unkari
Epirubicina	Argentiina, Ecuador, Espanja, Kolumbia, Meksiko, Romania
Epirubicine	Belgia, Ranska, Sveitsi
Farmarubicin	Turkki
Farmorubicin	Brasilia, Itävalta, Kreikka, Norja, Ruotsi, Saudi-Arabia, Suomi, Sveitsi, Tanska
Farmorubicin CSV	Etelä-Afrikka
Farmorubicin PFS	Kroatia, Puola, Slovenia
Farmorubicin RD	Brasilia, Puola, Sveitsi, venäjä
Farmorubicin RTU	Hollanti
Farmorubicina	Brasilia, Espanja, Italia, Portugali
Farmorubicine	Belgia, Ranska
Pharmorubicin	Iso-Britannia

Viitteet : Epirubicin hydrochloride

	tyyppi	julkaisu
148	Lehti	Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525	Lehti	De Vroe C, De Muynck C, Remon JP, Samsom M. A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. Int J Pharm 1990 ; 65: 49-56.
683	Lehti	Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 1990 ; 43: 265-272.
686	Lehti	Wood MJ, Irwin WJ, Scott DK. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther 1990 ; 15: 279-289.
887	Lehti	Pujol M, Munoz M, Prat J, Giona V, De Bolos J. Stability study of epirubicin in NaCl 0.9% injection. Ann Pharmacotherapy 1997 ; 31: 992-995.
1237	Lehti	Keusters L, Stolk LML, Umans R, Van Asten P. Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation. Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265	Lehti	Wood MJ, Irwin WJ, Scott DK. Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. J Clin Pharm Ther 1990 ; 15: 291-300.
1317	Lehti	Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J 1987 ; 238: 476-478.
1662	Lehti	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1823	Lehti	Sewell GJ, Rigby-Jones AE, Priston MJ. Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 2003 ; 28: 349-353.
1897	Lehti	Sautou-Miranda V, Brigas F, Thibault M, Chopineau J. Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. EJHP 2001 ; 7, 3: 108-115.
1955	Lehti	Trissel LA, Zhang Y. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Ann Pharmacotherapy 2005 ; 39: 280-283.
2168	Lehti	Ozdemir FA, Anilanmert B, Pekin M. Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257	Laboratorio	Stability of epirubicin "Ebewe" infusion solutions. Ebewe Pharma 2007
3473	Lehti	Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Int J Pharm 2015 ; 495, 2: 956-962.
3474	Laboratorio	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3632	Laboratorio	Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics Hospira 2017
3670	Lehti	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3708	ilmoitus	Sarakbi I, Thiesen J, Krämer I. Compatibility of epirubicin-loaded DC Beads with different contrast media. ECOP 2 Krakow 2014
3918	Lehti	Sarakbi I, Krämer I. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. J Oncol Pharm Practice 2016 ; 22: 749-756.
4352	Lehti	Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. J Clin Pharm Ther 2019 ; 44: 875-882.

Mentions Légales